When will VNRX's first positive Net Income quarter results be published?
Open Closed Tags Stats About Back to juan.al

When will VNRX's first positive Net Income quarter results be published?

Jun 1, 2022 - 18:08

Management said on May 13, 2022 that they expect to break even “in the next 2 years” [1]. Commercialization of the Vet Cancer Screening test through Heska can start “as early as late 2022” [2]. NETs product will start selling in 2022 in Europe and the US [1]. Mgmt also says that NETs opportunity is 2x-3x that of Vet, and they’re working on human cancer detection and monitoring too with a TAM bigger than NETs. VNRX also said that they don’t own manufacturing, they outsource that to, I assume, a company who is already manufacturing similar products and can therefore scale quickly.

  • <=2023: all stars align, Vet and NETs sell better than expected, no major disasters (new deadly covid variant, nuclear war, etc), good luck.
  • 2024: things go as currently planned, which, hopefully, means that the prediction takes into account past setbacks and delays.
  • 2025: major setbacks but nothing like covid and 2020
  • >=2026: deadly covid variant, nuclear war, company gets sued into bankruptcy

I assigned probabilities based on the principle that “things always take longer than anticipated” and also based on VNRX’s mgmt past prediction accuracy.

[1] https://volition.com/resources/press-room/video-gallery/capital-markets-day-2022 Minute 05:16. [2] https://www.prnewswire.com/news-releases/volition-signs-exclusive-28-million-license-and-supply-agreement-with-heska-corporation-to-distribute-nuq-vet-cancer-screening-test-at-the-point-of-care-301512651.html